• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
ALEXMED ePosters
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 7 (2025)
Volume Volume 6 (2024)
Volume Volume 5 (2023)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 4 (2022)
Volume Volume 3 (2021)
Volume Volume 2 (2020)
Volume Volume 1 (2019)
Elsamra, M., Elsaid, S., Zaghloul, R., Elsayed, A. (2023). EARLY SECOND TRIMESTER DYSLIPIDEMIA FOR PREDICTION OF OCCURRENCE OF PREECLAMPSIA. ALEXMED ePosters, 5(3), 58-59. doi: 10.21608/alexpo.2023.237290.1697
Mohamed Abdelmoety Elsamra; Samir Elsaid; Raghda Saad Zaghloul; Aya Ali Fouad Elsayed. "EARLY SECOND TRIMESTER DYSLIPIDEMIA FOR PREDICTION OF OCCURRENCE OF PREECLAMPSIA". ALEXMED ePosters, 5, 3, 2023, 58-59. doi: 10.21608/alexpo.2023.237290.1697
Elsamra, M., Elsaid, S., Zaghloul, R., Elsayed, A. (2023). 'EARLY SECOND TRIMESTER DYSLIPIDEMIA FOR PREDICTION OF OCCURRENCE OF PREECLAMPSIA', ALEXMED ePosters, 5(3), pp. 58-59. doi: 10.21608/alexpo.2023.237290.1697
Elsamra, M., Elsaid, S., Zaghloul, R., Elsayed, A. EARLY SECOND TRIMESTER DYSLIPIDEMIA FOR PREDICTION OF OCCURRENCE OF PREECLAMPSIA. ALEXMED ePosters, 2023; 5(3): 58-59. doi: 10.21608/alexpo.2023.237290.1697

EARLY SECOND TRIMESTER DYSLIPIDEMIA FOR PREDICTION OF OCCURRENCE OF PREECLAMPSIA

Article 1, Volume 5, Issue 3, September 2023, Page 58-59  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2023.237290.1697
View on SCiNiTO View on SCiNiTO
Authors
Mohamed Abdelmoety Elsamra1; Samir Elsaid2; Raghda Saad Zaghloul3; Aya Ali Fouad Elsayed email 1
1Department of Obstetrics and Gynecology, Faculty of Medicine, Alexandria University
2Department of Obstetrics and Gynecology, Faculty of Medicine, Alexandria University, Egypt
3Department of Clinical & chemical Patholohy**, Faculty of Medicine, Alexandria University, Egypt
Abstract
Pregnancy-related hypertensive disorders are still a major global health concern for both mothers and their unborn children.
Preeclampsia is defined: systolic blood pressure (SBP) greater than or equal to 140 mm Hg, diastolic blood pressure (DBP) more than or equal to 90 mm Hg, on two occasions as a minimum four hours apart in a patient who was previously normotensive patient and the co-occurrence of one or both of the resulting new-onset conditions:
• Urine protein: creatinine ratio ≥30 mg/mmol.
• Additional signs of maternal organ dysfunction, such as involvement of the kidneys or the liver, neurological or hemorrhagic issues, or uteroplacental dysfunction.
Lipid metabolic abnormalities have been identified as possible risk factors for the onset and progression of preeclampsia. These risk variables are also present in arthrosclerosis, which may indicate a shared pathogenesis.
The pathophysiology and development of preeclampsia are significantly influenced by lipids and lipid metabolism, including:
• Vascular dysfunction
• Defective trophoplastic invasion
• Triggering inflammatory processes
• Driving ferroptosis
Keywords
EARLY SECOND TRIMESTER; DYSLIPIDEMIA; PREECLAMPSIA
Supplementary Files
download 1697 22 (6).pdf
Statistics
Article View: 57
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.